Immunocore Holdings Plc (IMCR)
33.00
-0.05
(-0.15%)
USD |
NASDAQ |
Jan 09, 16:00
33.00
0.00 (0.00%)
After-Hours: 20:00
Immunocore Holdings EPS Diluted (Quarterly): -0.0035 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2955 |
| Tiziana Life Sciences Ltd. | -- |
| Aptorum Group Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1759M |
| Revenue (Quarterly) | 103.07M |
| Total Expenses (Quarterly) | 103.25M |
| Enterprise Value | 1.211B |
| Gross Profit Margin (Quarterly) | 98.74% |
| Profit Margin (Quarterly) | -0.17% |
| Earnings Yield | -1.77% |
| Normalized Earnings Yield | -2.452 |